Citation Impact
Citing Papers
The mevalonate pathway regulates microRNA activity in Caenorhabditis elegans
2012 StandoutNobel
Programmed cell death 1 ligand 1 and tumor-infiltrating CD8 + T lymphocytes are prognostic factors of human ovarian cancer
2007 StandoutNobel
Genetic variability of the AIDS virus: Nucleotide sequence analysis of two isolates from African patients
1986 StandoutNobel
Inflammation and cancer
2002 StandoutNature
S. cerevisiae α pheromone receptors activate a novel signal transduction pathway for mating partner discrimination
1991 StandoutNobel
MicroRNAs
2004 Standout
The molecular heterogeneity of protein kinase C and its implications for cellular regulation
1988 StandoutNature
Chromatin structure and transcriptional regulation of human papillomavirus type 18 DNA in hela cells
1989 StandoutNobel
Canarypox Vaccines Induce Antigen‐Specific Human γδ T Cells Capable of Interferon‐γ Production
2001
The Cold Shock Domain Protein LIN-28 Controls Developmental Timing in C. elegans and Is Regulated by the lin-4 RNA
1997 StandoutNobel
MicroRNAs: Target Recognition and Regulatory Functions
2009 Standout
The effect of the JE (MCP‐1) gene, which encodes monocyte chemoattractant protein‐1, on the growth of hela cells and derived somatic‐cell hybrids in nude mice
1995 StandoutNobel
Ectopic Expression of Nonliganded Retinoic Acid Receptor β Abrogates AP-1 Activity by Selective Degradation of c-Jun in Cervical Carcinoma Cells
2004 StandoutNobel
A nuclear pore complex protein that contains zinc finger motifs, binds DNA, and faces the nucleoplasm
1993 StandoutNobel
Genes and Mechanisms Related to RNA Interference Regulate Expression of the Small Temporal RNAs that Control C. elegans Developmental Timing
2001 StandoutNobel
Cross-Intron Bridging Interactions in the Yeast Commitment Complex Are Conserved in Mammals
1997 StandoutNobel
Poxvirus-based vaccine candidates for HIV: two decades of experience with special emphasis on canarypox vectors
2004
Disrupted dichotomous intracellular control of human papillomavirus infection in cancer of the cervix
1994 StandoutNobel
Spinning molecular immunology into successful immunotherapy
2002
HIV-1 Gag mutants can dominantly interfere with the replication of the wild-type virus
1989
Malignant progression of an HPV16-immortalized human keratinocyte cell line (HPKIA) in vitro
1995
The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans
2000 StandoutNatureNobel
Regulation by HIV Rev depends upon recognition of splice sites
1989 StandoutNobel
Genomic characterization and phylogenetic analysis of Zika virus circulating in the Americas
2016
Cis elements and Trans-acting factors involved in the RNA dimerization of the human immunodeficiency virus HIV-1
1990 StandoutNobel
CLIP170-like tip1p Spatially Organizes Microtubular Dynamics in Fission Yeast
2000 StandoutNobel
Selective down-regulation of human papillomavirus transcription by 2-deoxyglucose
1998 StandoutNobel
Restoration of p53 expression sensitizes human papillomavirus type 16 immortalized human keratinocytes to CD95-mediated apoptosis
2002 StandoutNobel
microRNAs
2001 StandoutNobel
Prime–boost immunization with poxvirus or adenovirus vectors as a strategy to develop a protective vaccine for HIV-1
2010
The functions of animal microRNAs
2004 StandoutNatureNobel
Conversion of HPV 18 positive non-tumorigenic HeLa-fibroblast hybrids to invasive growth involves loss of TNF-α mediated repression of viral transcription and modification of the AP-1 transcription complex
1999 StandoutNobel
Modeling neurodevelopmental disorder-associated humanAGO1mutations inCaenorhabditis elegansArgonautealg-1
2024 StandoutNobel
Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates
2011 StandoutNobel
Early protection against pathogenic virus infection at a mucosal challenge site after vaccination with attenuated simian immunodeficiency virus
2004 StandoutNobel
Extinction of the HPV18 upstream regulatory region in cervical carcinoma cells after fusion with non-tumorigenic human keratinocytes under non-selective conditions.
1991 StandoutNobel
Regulation of Rous sarcoma virus RNA splicing and stability.
1988
Novel cysteine-rich motif and homeodomain in the product of the Caenorhabditis elegans cell lineage gene lin-II
1990 StandoutNatureNobel
Control of Rous sarcoma virus RNA translation and packaging by the 5′ and 3′ untranslated sequences
1986
Nonsense Codons within the Rous Sarcoma Virus gag Gene Decrease the Stability of Unspliced Viral RNA
1991
HIV-1 reverse transcriptase specifically interacts with the anticodon domain of its cognate primer tRNA.
1989 StandoutNobel
Domainal evolution of a prokaryotic DNA repair protein and its relationship to active-transport proteins
1986 StandoutNatureNobel
Stabilization and ribosome association of unspliced pre-mRNAs in a yeast upf1- mutant.
1993 StandoutNobel
Zinc fingers and other metal-binding domains. Elements for interactions between macromolecules.
1990
Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A
2011 StandoutNobel
A feedback circuit involving let-7-family miRNAs and DAF-12 integrates environmental signals and developmental timing in Caenorhabditis elegans
2009 StandoutNobel
BIK1, a protein required for microtubule function during mating and mitosis in Saccharomyces cerevisiae, colocalizes with tubulin.
1990
Packaging of human immunodeficiency virus type 1 RNA requires cis-acting sequences outside the 5' leader region
1993
An experimental system for analyzing response to a morphogen gradient.
1996 StandoutNobel
Regulation of Caenorhabditis elegans neuronal polarity by heterochronic genes
2019 StandoutNobel
Selective suppression of human papillomavirus transcription in non-tumorigenic cells by 5-azacytidine.
1988 StandoutNobel
Disturbance of Tumor Necrosis Factor Alpha-Mediated Beta Interferon Signaling in Cervical Carcinoma Cells
2002 StandoutNobel
Translocation events in the evolution of aminoacyl-tRNA synthetases.
1996 StandoutNobel
Localized and inducible expression of Xenopus-posterior (Xpo), a novel gene active in early frog embryos, encoding a protein with a ‘CCHC’ finger domain
1991
Antioxidant-induced changes of the AP-1 transcription complex are paralleled by a selective suppression of human papillomavirus transcription
1997 StandoutNobel
Viruses in Human Cancers
1991 StandoutScienceNobel
Nonsense codons within the Rous sarcoma virus gag gene decrease the stability of unspliced viral RNA.
1991
Control of stem cell self-renewal and differentiation by the heterochronic genes and the cellular asymmetry machinery in Caenorhabditis elegans
2015 StandoutNobel
Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging result in production of noninfectious virus
1990
Transcriptional Regulation in Mammalian Cells by Sequence-Specific DNA Binding Proteins
1989 StandoutScience
Retinoic acid-mediated repression of human papillomavirus 18 transcription and different ligand regulation of the retinoic acid receptor beta gene in non-tumorigenic and tumorigenic HeLa hybrid cells.
1992 StandoutNobel
Differential regulation of the JE gene encoding the monocyte chemoattractant protein (MCP-1) in cervical carcinoma cells and derived hybrids
1994 StandoutNobel
The Leucine Zipper: A Hypothetical Structure Common to a New Class of DNA Binding Proteins
1988 StandoutScience
Vaccine-induced protection of chimpanzees against infection by a heterologous human immunodeficiency virus type 1
1995 StandoutNobel
Immunotherapy: Bewitched, Bothered, and Bewildered No More
2004 StandoutScienceNobel
In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
1996 StandoutScience
An essential splicing factor, SLU7, mediates 3' splice site choice in yeast.
1992
Potential Metal-Binding Domains in Nucleic Acid Binding Proteins
1986 Science
Structural basis for Zika envelope domain III recognition by a germline version of a recurrent neutralizing antibody
2020 StandoutNobel
Vaccines: the Fourth Century
2009
Identification of many microRNAs that copurify with polyribosomes in mammalian neurons
2003 StandoutNobel
Heterologous Human Immunodeficiency Virus Type 1 Priming-Boosting Immunization Strategies Involving Replication-Defective Adenovirus and Poxvirus Vaccine Vectors
2004
Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety.
1996
Structural relationships and the classification of aminoacyl-tRNA synthetases.
1991
Works of Claude Méric being referenced
Immunogenicity, safety and tolerability in adults of a new single-dose, live-attenuated vaccine against Japanese encephalitis: Randomised controlled phase 3 trials
2010
A Canarypox Vector–Expressing Cytomegalovirus (CMV) Phosphoprotein 65 Induces Long‐Lasting Cytotoxic T Cell Responses in Human CMV‐Seronegative Subjects
2001
A Prime-Boost Approach to HIV Preventive Vaccine Using a Recombinant Canarypox Virus Expressing Glycoprotein 160 (MN) followed by a Recombinant Glycoprotein 160 (MN/LAI)
1995
Mutations in Rous sarcoma virus nucleocapsid protein p12 (NC): deletions of Cys-His boxes
1988
Rous sarcoma virus nucleic acid-binding protein p12 is necessary for viral 70S RNA dimer formation and packaging
1986
It is Rous Sarcoma virus protein P12 and not P19 that binds tightly to Rous Sarcoma virus RNA
1984
Highly attenuated poxvirus vectors: NYVAC, ALVAC and TROVAC.
1995
A procedure for Northern blot analysis of native RNA
1986
Characterization of Moloney murine leukemia virus mutants with single-amino-acid substitutions in the Cys-His box of the nucleocapsid protein
1989